Bio-Bridge Science Announces Receipt of Papilloma Pseudovirus Technology Patent in Japan
April 12 2010 - 12:26PM
Business Wire
Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company
engaged in the commercial development of vaccines and
vaccine-related products announced today that the Japanese Patent
Office has granted claims in a patent application, and issued a
Patent Number 4472724, regarding the use of the papilloma
pseudovirus. Bio-Bridge Science has previously been granted patents
relating to the papilloma pseudovirus technology and preparation in
the United States and China. Loyola University Chicago owns the
patent and has exclusively licensed the technology to Bio-Bridge
Science, Inc.
“We are pleased to receive the patent from the Japanese Patent
Office,” said Dr. Liang Qiao, Chairman and CEO of Bio-Bridge
Science. “The addition of this new patent strengthens our
intellectual property portfolio focused on our papilloma
pseudovirus technology exclusively licensed from Loyola University
Chicago.”
This press release contains forward-looking statements.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and
service demand and acceptance, changes in technology, economic
conditions, the impact of competition and pricing, government
regulation, and other risks defined in this document and in
statements filed from time to time with the Securities and Exchange
Commission. All such forward-looking statements, whether written or
oral, and whether made by or on behalf of the company, are
expressly qualified by these cautionary statements and any other
cautionary statements which may accompany the forward-looking
statements. In addition, the company disclaims any obligation to
update any forward-looking statements to reflect events or
circumstances after the date hereof. Please refer to the Company's
SEC filings for additional information.
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bio Bridge Science Inc (CE) (OTCMarkets): 0 recent articles
More Bio-Bridge Science, Inc. News Articles